Since TPC-1 cells are derived from papillary thyroid carcinoma, they harbor mutations, such as RET/PTC rearrangement, which confer greater resistance to apoptosis and cell death (47–51). The gene discussed is RET; the disease is differentiated thyroid carcinoma.